Komori
Semiannual Report6092EnBio Holdings,IncServices

Semiannual Report — FY2026 H1

What EnBio Holdings,Inc reported for the period from 2026-04-01 to 2026-09-30.

How much it says
66Detailed
What moved here
35named for the first time
Its own wording
40terms
Which filing this is
35/ 35newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist

During the current interim consolidated accounting period, revenue was ¥5,756 million and ordinary income was ¥642 million, while interim net income attributable to owners of the parent was ¥394 million. In addition, the Board of Directors’ resolution to acquire a business involving residential solar power generation systems and other assets, and the execution of a business transfer agreement dated 16 October 2026, are disclosed as material subsequent events.

Komori's summary of this document, not the document's own words.
66Detailed
How much this filing saysA weighted roll-up of 10 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 37 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
73
Detailed
Magnitude of change
84
Very detailed
Strategic shift
74
Detailed
Capital movement
75
Very detailed
Disclosure gaps
53
Typical
Risk changes
27
Almost nothing
Financial and capital policy
69
Detailed
Specificity of disclosure
60
Detailed
Product portfolio
79
Very detailed
Technology position
50
Typical
Conviction behind strategic bets
R&D spend19百万円Money spent making new things.
Cash left over1億円Cash from the business, less what went into equipment.
Spent on equipmentNot disclosedThis document does not carry the figure.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.
EnBio Holdings,Inc — FY2026 H1 | Komori